Quantitative Analysis of the Biomechanical Contributors during the miniBEST Clinical Scale for Assessing Risk of Falling in Parkinson’s Disease
Objective: The objective of this study was to determine the most relevant biomechanical factors contributing to the risk of falling in those with Parkinson’s Disease…Assessing the Predictive Accuracy of Baseline Neuropsychiatric and Axial Motor Features for Freezing of Gait in Parkinson’s Disease at 5-year Follow up: The PPMI Cohort
Objective: To determine if neuropsychiatric and axial motor symptoms at baseline would be predictive of freezing of gait (FoG) at 5-year follow up in participants…Study of Cytokine profile in a Tunisian Parkinson’s Disease cohort
Objective: We aim to study the relationship between clinical features in patients with Parkinson’s disease (PD) and their IL-6 and IL-1β serum levels. Background: According…Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease
Objective: To investigate the decline in functionality according to WHODAS-2.0 from early to intermediate stages of PD. Background: Parkinson's disease (PD) is an incurable and…Beyond Memory:A Brain Health Awareness Kit for Spanish-speaking Communities
Objective: To develop an interactive workshop in Spanish that provides basic information about brain health and its importance so that community members can identify risk…Tremors Vs. Tremors: the first music album from Parkinson’s tremors
Objective: Tremors Vs. Tremors is a creative engagement project exploring the intersection between music, mood and tremor. The objective was to raise awareness of Parkinson’s…Role of the Alpha-synuclein Seed Amplification Assay in Parkinson’s Disease Clinical Trials: A Case Report of Multiple System Atrophy Misdiagnosed as Parkinson’s Disease
Objective: Report a patient with Multiple System Atrophy (MSA) misdiagnosed as Parkinson’s disease (PD) and enrolled in a clinical trial for PD treatment with Mesenchymal…AI for Personalized Medication Management in Parkinson’s Disease
Objective: To assess medication usage over time in Parkinson’s Disease utilizing AI in EHR data. Background: Parkinson's disease (PD) is a complex neurodegenerative disorder characterized…Beyond Clinical Presentation: Incorporating Neuroimaging and Biofluid Markers to Predict Progression of Parkinson’s Disease
Objective: To assess whether including measurements of neuroimaging and biofluid-based biomarkers improves predictive ability of models of motor and non-motor progression up to 5-year follow-up…Identifying key symptoms associated to parkinsonism other than Parkinson’s Disease: a case series
Objective: This study aims to identify the main symptoms associated with the clinical diagnosis of parkinsonism, excluding Parkinson's disease (PD), among patients evaluated by non-specialist…
- « Previous Page
- 1
- …
- 86
- 87
- 88
- 89
- 90
- …
- 338
- Next Page »